Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A G Hamilton

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Nature Communications|March 4, 2022
Obesity-induced galectin-9 is a therapeutic target in B-cell acute lymphoblastic leukemiaMiyoung Lee, Jamie A G Hamilton, Ganesh R Talekar, et al.
Scientific Reports|July 13, 2022
B-cell acute lymphoblastic leukemia promotes an immune suppressive microenvironment that can be overcome by IL-12Rae Hunter, Kathleen J Imbach, Chengjing Zhou, et al.
Aging Cell|January 22, 2021
Interleukin-37 improves T-cell-mediated immunity and chimeric antigen receptor T-cell therapy in aged backgroundsJamie A G Hamilton, Miyoung Y Lee, Rae Hunter, et al.
Biorxiv : the Preprint Server for Biology|February 14, 2024
The T-cell niche tunes immune function through modulation of the cytoskeleton and TCR-antigen forcesAnna V Kellner, Rae Hunter, Priscilla Do, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Nature Communications|March 4, 2022
Obesity-induced galectin-9 is a therapeutic target in B-cell acute lymphoblastic leukemiaMiyoung Lee, Jamie A G Hamilton, Ganesh R Talekar, et al.
Scientific Reports|July 13, 2022
B-cell acute lymphoblastic leukemia promotes an immune suppressive microenvironment that can be overcome by IL-12Rae Hunter, Kathleen J Imbach, Chengjing Zhou, et al.
Aging Cell|January 22, 2021
Interleukin-37 improves T-cell-mediated immunity and chimeric antigen receptor T-cell therapy in aged backgroundsJamie A G Hamilton, Miyoung Y Lee, Rae Hunter, et al.
Biorxiv : the Preprint Server for Biology|February 14, 2024
The T-cell niche tunes immune function through modulation of the cytoskeleton and TCR-antigen forcesAnna V Kellner, Rae Hunter, Priscilla Do, et al.
Pageof 2